by Marybeth Burke – Some of the most essential mainstays in cancer treatment drugs for adults and children are in short supply, Michael Link, M.D., president of the… read more.
by Marybeth Burke – The investigational drug BMS-936558 caused tumour shrinkage in up to a quarter of patients with advanced melanoma, kidney and NSCLC cancers,
by Marybeth Burke – Afatinib, an irreversible ErbB-family blocker, delays progression of advanced lung cancer in patients with epidermal growth factor receptor (EGFR) mutations compared with standard chemotherapy,
It is estimated that as many as 24 million European men aged 50 and over experience bothersome urinary symptoms.1,2 Yet, despite experiencing symptoms, men typically wait nearly two… read more.
by Bruce Sylvester – Emerging use of FDA Approved Drugs – Maraviroc, an antiretroviral drugin the treatment of HIV, significantly reduces the incidence of graft-versus-host disease (GvHD) among… read more.
by Bruce Sylvester – Emerging uses of FDA Approved Drugs – In some patients severe aplastic anemia who have failed standard therapies, eltrombopag appears to raise blood cell… read more.
by Bruce Sylvester – taken from The New England Journal of Medicine (NEJM) – Women treated with anastrozole and fulvestrant combination therapy have achieved over 6 months median… read more.
by Bruce Sylvester – taken from The Lancet – A study by Professor Peter M Rothwell, University of Oxford, UK and colleagues supports the hypothesis and adds to… read more.
by Gary Finnegan – World Health Matters (Sweden) – Breast cancer screening has limited or no impact on breast cancer mortality among women aged 40-69, according to a… read more.
Serrated polyposis is one of the most common polyp syndromes in clinical practice and is often unrecognized during colonoscopy.
The European Society for Medical Oncology (ESMO) has awarded ESMO Designated Center of Integrated Oncology and Palliative Care accreditation to 16 new oncology centres.
A new discovery that sheds light on the genetic make up of ovarian cancer cells could explain why some women survive longer than others with this deadly disease.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
